The D2194G mutation is responsible for increased levels of FV1 in carriers of the factor V R2 haplotype

Tomio Yamazaki; Hiromi Okada; Kristoffer W. Balling; Björn Dahlbäck; Gerry A. F. Nicolaes

doi:10.1160/TH10-03-0180

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 2010; 104(04): 860-861
DOI: 10.1160/TH10-03-0180

Letters to the Editor

Schattauer GmbH

The D2194G mutation is responsible for increased levels of FV1 in carriers of the factor V R2 haplotype

Tomio Yamazaki

¹Department of Laboratory Medicine, Division of Clinical Chemistry, Lund University, Wallenberg Laboratory, University Hospital, Malmö, Sweden

²Department of Hemostasis and Thrombosis, Clinical Research Center, Nagoya Medical Center, Nagoya Japan

,

Hiromi Okada

²Department of Hemostasis and Thrombosis, Clinical Research Center, Nagoya Medical Center, Nagoya Japan

,

Kristoffer W. Balling

¹Department of Laboratory Medicine, Division of Clinical Chemistry, Lund University, Wallenberg Laboratory, University Hospital, Malmö, Sweden

,

Björn Dahlbäck

¹Department of Laboratory Medicine, Division of Clinical Chemistry, Lund University, Wallenberg Laboratory, University Hospital, Malmö, Sweden

,

Gerry A. F. Nicolaes

¹Department of Laboratory Medicine, Division of Clinical Chemistry, Lund University, Wallenberg Laboratory, University Hospital, Malmö, Sweden

³Cardiovascular Research Institute Maastricht, Department of Biochemistry, Maastricht University, Maastricht, the Netherlands

› Author Affiliations

Abstract

Full Text

References

References
1 Nicolaes GAF, Villoutreix BO, Dahlbäck B. Partial glycosylation of Asn2181 in human factor V as a cause of molecular and functional heterogeneity. Modulation of glycosylation efficiency by mutagenesis of the consensus sequence for N-linked glycosylation.. Biochemistry 1999; 38: 13584-13591.
2 Hoekema L, Nicolaes GAF, Hemker HC. et al. Human factor Va1 and factor Va2: properties in the procoagulant and anticoagulant pathways.. Biochemistry 1997; 18 (36) 3331-3335.
3 Hoekema L, Castoldi E, Tans G. et al. Functional Properties of Factor V and Factor Va Encoded by the R2-gene.. Thromb Haemost 2001; 85: 75-81.
4 Yamazaki T, Nicolaes GAF, Sørensen KW. et al. Molecular basis of quantitative factor V deficiency associated with factor V R2 haplotype.. Blood 2002; 100: 2515-2521.
5 Miteva MA, Brugge JM, Rosing J. et al. Theoretical and experimental study of the D2194G mutation in the C2 domain of coagulation factor V.. Biophys J 2004; 86: 488-489.
6 Helenius A, Aebi M. Roles of N-linked glycans in the endoplasmic reticulum.. Annu Rev Biochem 2004; 73: 1019-1049.
7 van der Neut Kolfschoten M, Dirven RJ, Vos HL. et al. The R2-haplotype associated Asp2194Gly mutation in the light chain of human factor V results in lower expression levels of FV, but has no influence on the glycosylation of Asn2181.. Thromb Haemost 2003; 89: 429-437.
8 Govers-Riemslag JW, Castoldi E, Nicolaes GAF. et al. Reduced factor V concentration and altered FV1/FV2 ratio do not fully explain R2-associated APC-resistance.. Thromb Haemost 2002; 88: 444-449.
9 Hansson K, Stenflo J. Post-translational modifications in proteins involved in blood coagulation.. J Thromb Haemost 2005; 3: 2633-2648.